NAD(H)-dependent corepressor CTBP1 integrates metabolic signals to drive oncogenic programs

Area of Science:

• Molecular Biology
• Cancer Biology
• Epigenetics

Background:

• C-terminal binding protein 1 (CTBP1) is an NAD(H)-dependent transcriptional corepressor.
• CTBP1 integrates cellular metabolism, redox cues, and epigenetic regulation.
• CTBP1 is implicated in various developmental and pathological processes, notably cancer.

Purpose of the Study:

• To review the structure, regulation, and function of CTBP1.
• To focus on CTBP1's role in cancer biology.
• To critically examine CTBP1's potential as a therapeutic target.

Main Methods:

• Literature review of experimental studies.
• Synthesis of findings on CTBP1's oncogenic roles.
• Analysis of evidence supporting CTBP1's function in malignancies.

Main Results:

• CTBP1 acts as an oncogenic driver in specific cancer contexts.
• Evidence for CTBP1's role is sometimes indirect or incomplete.
• CTBP1's functions are context-dependent and influenced by metabolic stress.

Conclusions:

• CTBP1 is a context-dependent transcriptional integrator.
• Therapeutic strategies targeting CTBP1 face challenges like mechanistic validation and toxicity.
• Further research is needed to fully evaluate CTBP1 as a therapeutic target.